ArticleBriefings in bioinformatics2026
PathCLAST: pathway-augmented contrastive learning with attention for interpretable spatial transcriptomics.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A comprehensive survey of computer vision methods for spatial transcriptomics.Briefings in bioinformatics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deciphering how molecular programs are spatially organized within tissues is pivotal for understanding tumor evolution and microenvironmental interactions. Existing spatial transcriptomics tools either rely on gene-level features, ignoring the rich topology of biological pathways, or deliver black-box clusters with little mechanistic insight; thus, they limit their translational impact. A method that simultaneously leverages pathway structures and spatially matched histopathology could produce domain delineations that are both accurate and biologically interpretable. We introduce PathCLAST (Pathway-augmented Contrastive Learning with Attention for interpretable Spatial Transcriptomics), which is a framework that integrates gene expression, histopathological images, and curated pathway graphs via bi-modal contrastive learning. By embedding expression profiles into biologically structured graphs, and aligning them with local image features, PathCLAST achieves state-of-the-art spatial domain identification on multiple public datasets, while offering pathway-level attention scores for mechanistic interpretation. The pathway embedding also serves as an explicit, biology-informed dimensionality reduction scheme. PathCLAST not only uncovers domain-specific pathways and spatially organized signaling activities, but also quantifies intra-domain heterogeneity, spatial autocorrelation, and inter-domain crosstalk, providing fine-grained insights into tumor progression and tissue architecture. PathCLAST is available at https://github.com/sslim-aidrug/PathCLAST.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.